Patents
Affitech Strengthens Patent Position on its Phagemid Antibody Screening Technology in Europe
Published in Cancer Weekly, April 14th, 2009
The human antibody company, Affitech AS announced that the European Patent Office has granted an European patent on the use of phagemid particles having an antibody-coliphage pIII fusion protein, to identify tumor associated antigens on cells by negative selection. The new patent (EP 1065271) is part of the "Breitling" family of patents, originally filed by the German Cancer Research Centre, (Heidelberg, Germany), which is exclusively licensed to Affitech AS.
The Breitling family of patents covers the use of full-length pIII phage protein as a scaffold in a phagemid vector, and is one of the fundamental groups of patents for the phagemid display of antibody, antibody...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-04-14)
More Articles from Cancer Weekly
- BG Medicine Inc.
BG Medicine Inc. Launches Galectin-3 Website and Commences Galectin-3 Assay Service for Clinical Research - Cancer
Palonosetron "Preferred" 5-HT3 Antagonist for Emesis Prevention in Oncology Patients Receiving Highly Emetogenic Chemotherapy - Cancer
Report Defines Need for Patients' Voice in Healthcare Reform - Cancer Gene Therapy
Data on cancer gene therapy detailed by researchers at University of Kuopio - Cancer Vaccines
Study results from M.A. Habel and colleagues in the area of cancer vaccines published - Celsion Corporation
Celsion Announces Promising ThermoDox® Clinical Results in Primary Liver Cancer Were Published in Expert Opinion - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
